Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06711432Recruiting
Randomised, single-blind trial (2 arms), sponsored by Zhejiang Cancer Hospital. Primary endpoint: Incidence of Postoperative Delirium and Cognitive Impairment at 1 week. Started Sep 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06711432.